Availability of the third edition (1997) of the European Pharmacopeia has been announced by the Council of Europe press service. On January 1, 1997, its norms and specifications will come into force for the 25 countries which have signed the convention, or otherwise they will replace national specifications where they already exist for the same subject. The Pharmacopeia is designed to correspond to the specific needs of licensing authorities concerned with medicines for human and veterinary use, as well as for drugmakers.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze